246 related articles for article (PubMed ID: 30915748)
1. Down-regulation of miR-5702 is associated with clinical progression and poor prognosis in patients with non-small-cell lung cancer.
Li K; Xu Y; Yuan LN
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2047-2052. PubMed ID: 30915748
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
Liu L; Qu W; Zhong Z
Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
Chen SW; Wang TB; Tian YH; Zheng YG
Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
[TBL] [Abstract][Full Text] [Related]
5. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-153 expression and prognosis in non-small cell lung cancer.
Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW
Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455
[TBL] [Abstract][Full Text] [Related]
7. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
8. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
9. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival.
Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM
Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer.
Zhong KZ; Chen WW; Hu XY; Jiang AL; Zhao J
Int J Clin Exp Pathol; 2014; 7(7):4545-51. PubMed ID: 25120851
[TBL] [Abstract][Full Text] [Related]
12. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of microRNA-124 is correlated with tumor metastasis and poor prognosis in patients with lung cancer.
Zhang Y; Li H; Han J; Zhang Y
Int J Clin Exp Pathol; 2015; 8(2):1967-72. PubMed ID: 25973090
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of microRNA-301a in nonsmall-cell lung cancer and its clinical significance.
Shi YK; Zang QL; Li GX; Huang Y; Wang SZ
J Cancer Res Ther; 2016; 12(2):693-8. PubMed ID: 27461635
[TBL] [Abstract][Full Text] [Related]
16. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells.
Du Z; Wu J; Wang J; Liang Y; Zhang S; Shang Z; Zuo W
Diagn Pathol; 2019 Dec; 14(1):132. PubMed ID: 31801557
[TBL] [Abstract][Full Text] [Related]
18. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
[TBL] [Abstract][Full Text] [Related]
20. Increasing expression of miR-5100 in non-small-cell lung cancer and correlation with prognosis.
Wang T; Liu X; Tian Q; Liang T; Chang P
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3592-3597. PubMed ID: 28925485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
